Advertisement
Advertisement
OKYO
OKYO Pharma Limited Ordinary Shares
1.68
USDSponsored
+0.02
+1.20%
Jul 31, 15:37 UTC -4
Closed
After-Market
1.68
0.00
-0.30%
OKYO Earnings Reports
Positive Surprise Ratio
No Data Available for OKYO
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
OKYO Pharma Limited Ordinary Shares earnings per share and revenue
On Jul 20, 2026, OKYO reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.08 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Agios Pharmaceuticals, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$1.70
Actual
-$1.69
Surprise
+0.66%
Castle Biosciences, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.41
Actual
-$0.07
Surprise
+83.12%
Myriad Genetics Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.25
Surprise
-323.73%
Crescent Biopharma, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.81
Actual
-$0.74
Surprise
+8.74%
Bristol-Myers Squibb Co.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.60
Actual
$2.04
Surprise
+27.20%
Regeneron Pharmaceuticals Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
$10.46
Actual
$14.29
Surprise
+36.51%
Moderna, Inc. Common Stock
Report Date
Jul 31, 2026 For Q2 26
Estimate
-$2.12
Actual
-$1.97
Surprise
+7.28%
Illumina Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.38
Actual
$1.31
Surprise
-5.30%
Guardant Health, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
-$0.41
Actual
-$0.42
Surprise
-0.02%
PTC Therapeutics, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.42
Actual
$0.92
Surprise
+116.37%
FAQ
What were OKYO Pharma Limited Ordinary Shares's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, OKYO Pharma Limited Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to OKYO Pharma Limited Ordinary Shares's Q4 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is OKYO Pharma Limited Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for OKYO Pharma Limited Ordinary Shares's next earnings report?
Based on --
analysts, OKYO Pharma Limited Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement